Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

ANI Pharma Inc (NQ: ANIP )

34.76 USD UNCHANGED
Streaming Delayed Price Updated: 8:00 AM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 34.76
Bid (Size) 29.00 (3)
Ask (Size) 39.00 (2)
Prev. Close 34.76
Today's Range 34.76 - 34.76
52wk Range 23.55 - 48.45
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs
ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ:ANIP) today announced that it has acquired the new drug applications (“NDAs”) for OXISTAT® Lotion, VEREGEN® Ointment, and Pandel® Cream and the abbreviated new... 
From Business Wire News Releases
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and 12 months ended December 31, 2020. 
From Business Wire News Releases

Performance

YTD
+15.02%
+15.02%
1 Month
+5.33%
+5.33%
3 Month
+8.29%
+8.29%
6 Month
+19.00%
+19.00%
1 Year
-18.92%
-18.92%

More News

Read More
ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business
From Business Wire News Releases
Sum Up The Pieces: PSCH Could Be Worth $206
Tags ETFs
From ETF Channel
ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth
From Business Wire News Releases
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
From Business Wire News Releases
ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules
From Business Wire News Releases
ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets
From Business Wire News Releases
ANI Pharmaceuticals (ANIP) Shares Cross Above 200 DMA
Tags Stocks
From Market News Video
ANI Pharmaceuticals Reports Third Quarter 2020 Results
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.